Taking Topiramate and Mounjaro Together: What the Evidence Says

Why Mounjaro's effect on gastric emptying matters for topiramate

Mounjaro slows the movement of food through the stomach. That is part of why people feel full for longer on it. The consequence for other medicines is that absorption can be delayed — oral drugs taken alongside it may reach peak plasma levels later than expected, or at a lower peak. Topiramate is absorbed primarily in the small intestine, so any delay in gastric emptying could, in theory, alter the concentration curve.

In practice, the Mounjaro SmPC (available on the eMC) notes that the effect on concomitant oral medicines should be considered, particularly for drugs with a narrow therapeutic index. Topiramate does not carry a narrow therapeutic index label, which lowers the concern somewhat. Still, if you have been seizure-free for a period on a stable dose of topiramate, you and your neurologist will want to know that anything altering its absorption profile is being introduced.

The practical upshot: this is a question for your prescriber and ideally for whoever manages your topiramate, whether that is a neurologist or your GP. It is not a reason to rule out Mounjaro outright, but it is a reason to start at the lowest dose and monitor carefully.

The overlapping side-effect profile, and where it gets specific

Topiramate and Mounjaro share several side effects, and when medicines overlap in this way, the combined burden can be heavier than either alone.

Both can cause appetite suppression and weight loss, which may sound like a bonus, but carries a real risk of inadequate protein and micronutrient intake if it is not actively managed. Both can cause cognitive slowing or difficulty concentrating in some people, though this is more established with topiramate. Both can cause nausea, particularly at the start of treatment or after a dose increase. And topiramate carries a well-documented risk of kidney stones, partly because it reduces citrate excretion; Mounjaro's gastrointestinal effects can compound this by causing nausea that leads to lower fluid intake. Staying well-hydrated matters more when both medicines are in the picture.

None of these overlaps are absolute bars to using the combination. They are factors a prescriber weighs when deciding whether the benefit-to-risk balance is right for you. If you are curious how this compares to other combination questions, our page on taking metformin and Mounjaro together covers a different but similarly common scenario.

Contraception is a separate but urgent point here

This matters more when topiramate is involved. The MHRA advises women of childbearing age to use contraception while taking Mounjaro and for a wash-out period before trying to conceive. Mounjaro can reduce the absorption of oral contraceptives during the first four weeks of treatment and for four weeks after each dose increase, so a non-oral method such as condoms is recommended during those windows.

Topiramate adds a second layer: it is a potent teratogen, and it also reduces the effectiveness of hormonal contraceptives by inducing certain liver enzymes. If you are managing contraception while taking topiramate, you may already be on a non-hormonal method or a higher-dose pill advised by your neurologist. Either way, tell your prescriber at consultation, this is exactly the kind of combined risk that our clinical team looks at when reviewing a full medicine list, not just the headline contraindication table.

For context on what Mounjaro treatment costs privately and what is included in that price, the Mounjaro UK pricing page gives an honest breakdown of the current market picture.

How the prescriber makes the call, and what you should bring to that conversation

When you complete a consultation for Mounjaro, you will be asked about your current medicines. Listing topiramate is important, and so is noting the dose, how long you have been on it, and which condition it is managing. Epilepsy and migraine carry different considerations: stable epilepsy may mean your neurologist needs to be looped in; migraine may mean a simpler conversation.

A prescriber can also consider whether starting Mounjaro at 2.5mg and titrating slowly gives time to spot any change in topiramate's effect before the dose increases further. Evidence checks and a review of your Summary Care Record are part of how our prescribers approach these decisions at nume. If you also take other medicines alongside topiramate (some people are on several) the Mysimba and Mounjaro and orlistat and Mounjaro pages cover how similar combination questions are handled.

One practical note: if your next prescription review with your neurologist falls mid-month or around a bank holiday, it is worth timing your Mounjaro consultation to happen after that conversation so any updated advice is already factored in. Readers combining tirzepatide with supplements or other peptides may also find it useful to read about whether berberine and tirzepatide can be taken together, or to check our guidance on taking sermorelin alongside tirzepatide, before speaking to a prescriber. Speak to our prescribers once you have the clearest possible picture of your current treatment.